 | • レポートコード：D005-07370 • 出版社/出版日：GlobalInfoResearch / 2020年5月22日 ※2024年版があります。お問い合わせください。 • レポート形態：英文、PDF、100ページ • 納品方法：Eメール • 産業分類：医療・製薬 |
| Single User | ￥515,040 (USD3,480) | ▷ お問い合わせ |
| Multi User | ￥772,560 (USD5,220) | ▷ お問い合わせ |
| Corporate User | ￥1,030,080 (USD6,960) | ▷ お問い合わせ |
• お支払方法：銀行振込（納品後、ご請求書送付）
レポート概要
| 本調査レポートでは、ジェネリック腫瘍滅菌注射の世界市場を広く調査・分析し、今後の市場展望をまとめております。ジェネリック腫瘍滅菌注射の種類別市場規模（化学療法、モノクローナル抗体、サイトカイン、ペプチドホルモン）、用途別市場規模（病院薬局、小売薬局、オンライン薬局）、地域別市場規模（北米、アメリカ、ヨーロッパ、アジア、中国、日本、東南アジア、南米、中東、アフリカなど）、市場動向、メーカー別販売量と市場シェア、販売チャネルなどの情報を掲載しています。 ・市場概要 ・メーカー情報（販売量、市場シェア、製品概要、SWOT分析）：Eli Lilly & Company、Pfizer Inc、Hikma Pharmaceuticals PLC、Biocon Ltd、Teva Pharmaceutical Industries Ltd.、Baxter International Inc、Sandoz International GmbH、Mylan N.V ・地域別グローバル市場分析 2015年-2020年 ・ジェネリック腫瘍滅菌注射の北米市場（アメリカ、カナダ、メキシコ） ・ジェネリック腫瘍滅菌注射のヨーロッパ市場（ドイツ、イギリス、フランス、ロシア、イタリア） ・ジェネリック腫瘍滅菌注射のアジア市場（中国、日本、韓国、インド、東南アジア、オーストラリア） ・ジェネリック腫瘍滅菌注射の南米市場（ブラジル、アルゼンチン） ・ジェネリック腫瘍滅菌注射の中東・アフリカ市場（サウジアラビア、トルコ、エジプト、南アフリカ） ・種類別分析：化学療法、モノクローナル抗体、サイトカイン、ペプチドホルモン ・用途別分析：病院薬局、小売薬局、オンライン薬局 ・地域別市場規模予測 2021年-2025年 ・販売チャネル、流通業者、代理店 ・調査の結果・結論 |
Market Overview
The global Generic Oncology Sterile Injectable market size is expected to gain market growth in the forecast period of 2020 to 2025, with a CAGR of 6.2% in the forecast period of 2020 to 2025 and will expected to reach USD 12600 million by 2025, from USD 9912.3 million in 2019.
The Generic Oncology Sterile Injectable market report provides a detailed analysis of global market size, regional and country-level market size, segmentation market growth, market share, competitive Landscape, sales analysis, impact of domestic and global market players, value chain optimization, trade regulations, recent developments, opportunities analysis, strategic market growth analysis, product launches, area marketplace expanding, and technological innovations.
Market segmentation
Generic Oncology Sterile Injectable market is split by Type and by Application. For the period 2015-2025, the growth among segments provide accurate calculations and forecasts for sales by Type and by Application in terms of volume and value. This analysis can help you expand your business by targeting qualified niche markets.
By Type, Generic Oncology Sterile Injectable market has been segmented into
Chemotherapy
Monoclonal Antibodies
Cytokines
Peptide Hormones
By Application, Generic Oncology Sterile Injectable has been segmented into:
Hospital Pharmacies
Retail Pharmacies
Online Pharmacies
Regions and Countries Level Analysis
Regional analysis is another highly comprehensive part of the research and analysis study of the global Generic Oncology Sterile Injectable market presented in the report. This section sheds light on the sales growth of different regional and country-level Generic Oncology Sterile Injectable markets. For the historical and forecast period 2015 to 2025, it provides detailed and accurate country-wise volume analysis and region-wise market size analysis of the global Generic Oncology Sterile Injectable market.
The report offers in-depth assessment of the growth and other aspects of the Generic Oncology Sterile Injectable market in important countries (regions), including:
North America (United States, Canada and Mexico)
Europe (Germany, France, UK, Russia and Italy)
Asia-Pacific (China, Japan, Korea, India and Southeast Asia)
South America (Brazil, Argentina, etc.)
Middle East & Africa (Saudi Arabia, Egypt, Nigeria and South Africa)
Competitive Landscape and Generic Oncology Sterile Injectable Market Share Analysis
Generic Oncology Sterile Injectable competitive landscape provides details by vendors, including company overview, company total revenue (financials), market potential, global presence, Generic Oncology Sterile Injectable sales and revenue generated, market share, price, production sites and facilities, SWOT analysis, product launch. For the period 2015-2020, this study provides the Generic Oncology Sterile Injectable sales, revenue and market share for each player covered in this report.
The major players covered in Generic Oncology Sterile Injectable are:
Eli Lilly & Company
Pfizer Inc
Hikma Pharmaceuticals PLC
Biocon Ltd
Teva Pharmaceutical Industries Ltd.
Baxter International Inc
Sandoz International GmbH
Mylan N.V
Among other players domestic and global, Generic Oncology Sterile Injectable market share data is available for global, North America, Europe, Asia-Pacific, Middle East and Africa and South America separately. Global Info Research analysts understand competitive strengths and provide competitive analysis for each competitor separately.
The content of the study subjects, includes a total of 15 chapters:
Chapter 1, to describe Generic Oncology Sterile Injectable product scope, market overview, market opportunities, market driving force and market risks.
Chapter 2, to profile the top manufacturers of Generic Oncology Sterile Injectable, with price, sales, revenue and global market share of Generic Oncology Sterile Injectable in 2018 and 2019.
Chapter 3, the Generic Oncology Sterile Injectable competitive situation, sales, revenue and global market share of top manufacturers are analyzed emphatically by landscape contrast.
Chapter 4, the Generic Oncology Sterile Injectable breakdown data are shown at the regional level, to show the sales, revenue and growth by regions, from 2015 to 2020.
Chapter 5, 6, 7, 8 and 9, to break the sales data at the country level, with sales, revenue and market share for key countries in the world, from 2015 to 2020.
Chapter 10 and 11, to segment the sales by type and application, with sales market share and growth rate by type, application, from 2015 to 2020.
Chapter 12, Generic Oncology Sterile Injectable market forecast, by regions, type and application, with sales and revenue, from 2020 to 2025.
Chapter 13, 14 and 15, to describe Generic Oncology Sterile Injectable sales channel, distributors, customers, research findings and conclusion, appendix and data source.
Table of Contents
1 Market Overview
1.1 Generic Oncology Sterile Injectable Introduction
1.2 Market Analysis by Type
1.2.1 Overview: Global Generic Oncology Sterile Injectable Revenue by Type: 2015 VS 2019 VS 2025
1.2.2 Chemotherapy
1.2.3 Monoclonal Antibodies
1.2.4 Cytokines
1.2.5 Peptide Hormones
1.3 Market Analysis by Application
1.3.1 Overview: Global Generic Oncology Sterile Injectable Revenue by Application: 2015 VS 2019 VS 2025
1.3.2 Hospital Pharmacies
1.3.3 Retail Pharmacies
1.3.4 Online Pharmacies
1.4 Overview of Global Generic Oncology Sterile Injectable Market
1.4.1 Global Generic Oncology Sterile Injectable Market Status and Outlook (2015-2025)
1.4.2 North America (United States, Canada and Mexico)
1.4.3 Europe (Germany, France, United Kingdom, Russia and Italy)
1.4.4 Asia-Pacific (China, Japan, Korea, India and Southeast Asia)
1.4.5 South America, Middle East & Africa
1.5 Market Dynamics
1.5.1 Market Opportunities
1.5.2 Market Risk
1.5.3 Market Driving Force
2 Manufacturers Profiles
2.1 Eli Lilly & Company
2.1.1 Eli Lilly & Company Details
2.1.2 Eli Lilly & Company Major Business and Total Revenue (Financial Highlights) Analysis
2.1.3 Eli Lilly & Company SWOT Analysis
2.1.4 Eli Lilly & Company Product and Services
2.1.5 Eli Lilly & Company Generic Oncology Sterile Injectable Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
2.2 Pfizer Inc
2.2.1 Pfizer Inc Details
2.2.2 Pfizer Inc Major Business and Total Revenue (Financial Highlights) Analysis
2.2.3 Pfizer Inc SWOT Analysis
2.2.4 Pfizer Inc Product and Services
2.2.5 Pfizer Inc Generic Oncology Sterile Injectable Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
2.3 Hikma Pharmaceuticals PLC
2.3.1 Hikma Pharmaceuticals PLC Details
2.3.2 Hikma Pharmaceuticals PLC Major Business and Total Revenue (Financial Highlights) Analysis
2.3.3 Hikma Pharmaceuticals PLC SWOT Analysis
2.3.4 Hikma Pharmaceuticals PLC Product and Services
2.3.5 Hikma Pharmaceuticals PLC Generic Oncology Sterile Injectable Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
2.4 Biocon Ltd
2.4.1 Biocon Ltd Details
2.4.2 Biocon Ltd Major Business and Total Revenue (Financial Highlights) Analysis
2.4.3 Biocon Ltd SWOT Analysis
2.4.4 Biocon Ltd Product and Services
2.4.5 Biocon Ltd Generic Oncology Sterile Injectable Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
2.5 Teva Pharmaceutical Industries Ltd.
2.5.1 Teva Pharmaceutical Industries Ltd. Details
2.5.2 Teva Pharmaceutical Industries Ltd. Major Business and Total Revenue (Financial Highlights) Analysis
2.5.3 Teva Pharmaceutical Industries Ltd. SWOT Analysis
2.5.4 Teva Pharmaceutical Industries Ltd. Product and Services
2.5.5 Teva Pharmaceutical Industries Ltd. Generic Oncology Sterile Injectable Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
2.6 Baxter International Inc
2.6.1 Baxter International Inc Details
2.6.2 Baxter International Inc Major Business and Total Revenue (Financial Highlights) Analysis
2.6.3 Baxter International Inc SWOT Analysis
2.6.4 Baxter International Inc Product and Services
2.6.5 Baxter International Inc Generic Oncology Sterile Injectable Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
2.7 Sandoz International GmbH
2.7.1 Sandoz International GmbH Details
2.7.2 Sandoz International GmbH Major Business and Total Revenue (Financial Highlights) Analysis
2.7.3 Sandoz International GmbH SWOT Analysis
2.7.4 Sandoz International GmbH Product and Services
2.7.5 Sandoz International GmbH Generic Oncology Sterile Injectable Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
2.8 Mylan N.V
2.8.1 Mylan N.V Details
2.8.2 Mylan N.V Major Business and Total Revenue (Financial Highlights) Analysis
2.8.3 Mylan N.V SWOT Analysis
2.8.4 Mylan N.V Product and Services
2.8.5 Mylan N.V Generic Oncology Sterile Injectable Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
3 Sales, Revenue and Market Share by Manufacturer
3.1 Global Generic Oncology Sterile Injectable Sales and Market Share by Manufacturer (2018-2019)
3.2 Global Generic Oncology Sterile Injectable Revenue and Market Share by Manufacturer (2018-2019)
3.3 Market Concentration Rate
3.3.1 Top 3 Generic Oncology Sterile Injectable Manufacturer Market Share in 2019
3.3.2 Top 6 Generic Oncology Sterile Injectable Manufacturer Market Share in 2019
3.4 Market Competition Trend
4 Global Market Analysis by Regions
4.1 Global Generic Oncology Sterile Injectable Sales, Revenue and Market Share by Regions
4.1.1 Global Generic Oncology Sterile Injectable Sales and Market Share by Regions (2015-2020)
4.1.2 Global Generic Oncology Sterile Injectable Revenue and Market Share by Regions (2015-2020)
4.2 North America Generic Oncology Sterile Injectable Sales and Growth Rate (2015-2020)
4.3 Europe Generic Oncology Sterile Injectable Sales and Growth Rate (2015-2020)
4.4 Asia-Pacific Generic Oncology Sterile Injectable Sales and Growth Rate (2015-2020)
4.5 South America Generic Oncology Sterile Injectable Sales and Growth Rate (2015-2020)
4.6 Middle East and Africa Generic Oncology Sterile Injectable Sales and Growth Rate (2015-2020)
5 North America by Country
5.1 North America Generic Oncology Sterile Injectable Sales, Revenue and Market Share by Country
5.1.1 North America Generic Oncology Sterile Injectable Sales and Market Share by Country (2015-2020)
5.1.2 North America Generic Oncology Sterile Injectable Revenue and Market Share by Country (2015-2020)
5.2 United States Generic Oncology Sterile Injectable Sales and Growth Rate (2015-2020)
5.3 Canada Generic Oncology Sterile Injectable Sales and Growth Rate (2015-2020)
5.4 Mexico Generic Oncology Sterile Injectable Sales and Growth Rate (2015-2020)
6 Europe by Country
6.1 Europe Generic Oncology Sterile Injectable Sales, Revenue and Market Share by Country
6.1.1 Europe Generic Oncology Sterile Injectable Sales and Market Share by Country (2015-2020)
6.1.2 Europe Generic Oncology Sterile Injectable Revenue and Market Share by Country (2015-2020)
6.2 Germany Generic Oncology Sterile Injectable Sales and Growth Rate (2015-2020)
6.3 UK Generic Oncology Sterile Injectable Sales and Growth Rate (2015-2020)
6.4 France Generic Oncology Sterile Injectable Sales and Growth Rate (2015-2020)
6.5 Russia Generic Oncology Sterile Injectable Sales and Growth Rate (2015-2020)
6.6 Italy Generic Oncology Sterile Injectable Sales and Growth Rate (2015-2020)
7 Asia-Pacific by Regions
7.1 Asia-Pacific Generic Oncology Sterile Injectable Sales, Revenue and Market Share by Regions
7.1.1 Asia-Pacific Generic Oncology Sterile Injectable Sales and Market Share by Regions (2015-2020)
7.1.2 Asia-Pacific Generic Oncology Sterile Injectable Revenue and Market Share by Regions (2015-2020)
7.2 China Generic Oncology Sterile Injectable Sales and Growth Rate (2015-2020)
7.3 Japan Generic Oncology Sterile Injectable Sales and Growth Rate (2015-2020)
7.4 Korea Generic Oncology Sterile Injectable Sales and Growth Rate (2015-2020)
7.5 India Generic Oncology Sterile Injectable Sales and Growth Rate (2015-2020)
7.6 Southeast Asia Generic Oncology Sterile Injectable Sales and Growth Rate (2015-2020)
7.7 Australia Generic Oncology Sterile Injectable Sales and Growth Rate (2015-2020)
8 South America by Country
8.1 South America Generic Oncology Sterile Injectable Sales, Revenue and Market Share by Country
8.1.1 South America Generic Oncology Sterile Injectable Sales and Market Share by Country (2015-2020)
8.1.2 South America Generic Oncology Sterile Injectable Revenue and Market Share by Country (2015-2020)
8.2 Brazil Generic Oncology Sterile Injectable Sales and Growth Rate (2015-2020)
8.3 Argentina Generic Oncology Sterile Injectable Sales and Growth Rate (2015-2020)
9 Middle East & Africa by Countries
9.1 Middle East & Africa Generic Oncology Sterile Injectable Sales, Revenue and Market Share by Country
9.1.1 Middle East & Africa Generic Oncology Sterile Injectable Sales and Market Share by Country (2015-2020)
9.1.2 Middle East & Africa Generic Oncology Sterile Injectable Revenue and Market Share by Country (2015-2020)
9.2 Saudi Arabia Generic Oncology Sterile Injectable Sales and Growth Rate (2015-2020)
9.3 Turkey Generic Oncology Sterile Injectable Sales and Growth Rate (2015-2020)
9.4 Egypt Generic Oncology Sterile Injectable Sales and Growth Rate (2015-2020)
9.5 South Africa Generic Oncology Sterile Injectable Sales and Growth Rate (2015-2020)
10 Market Segment by Type
10.1 Global Generic Oncology Sterile Injectable Sales and Market Share by Type (2015-2020)
10.2 Global Generic Oncology Sterile Injectable Revenue and Market Share by Type (2015-2020)
10.3 Global Generic Oncology Sterile Injectable Price by Type (2015-2020)
11 Global Generic Oncology Sterile Injectable Market Segment by Application
11.1 Global Generic Oncology Sterile Injectable Sales Market Share by Application (2015-2020)
11.2 Global Generic Oncology Sterile Injectable Revenue Market Share by Application (2015-2020)
11.3 Global Generic Oncology Sterile Injectable Price by Application (2015-2020)
12 Market Forecast
12.1 Global Generic Oncology Sterile Injectable Sales, Revenue and Growth Rate (2021-2025)
12.2 Generic Oncology Sterile Injectable Market Forecast by Regions (2021-2025)
12.2.1 North America Generic Oncology Sterile Injectable Market Forecast (2021-2025)
12.2.2 Europe Generic Oncology Sterile Injectable Market Forecast (2021-2025)
12.2.3 Asia-Pacific Generic Oncology Sterile Injectable Market Forecast (2021-2025)
12.2.4 South America Generic Oncology Sterile Injectable Market Forecast (2021-2025)
12.2.5 Middle East & Africa Generic Oncology Sterile Injectable Market Forecast (2021-2025)
12.3 Generic Oncology Sterile Injectable Market Forecast by Type (2021-2025)
12.3.1 Global Generic Oncology Sterile Injectable Sales Forecast by Type (2021-2025)
12.3.2 Global Generic Oncology Sterile Injectable Market Share Forecast by Type (2021-2025)
12.4 Generic Oncology Sterile Injectable Market Forecast by Application (2021-2025)
12.4.1 Global Generic Oncology Sterile Injectable Sales Forecast by Application (2021-2025)
12.4.2 Global Generic Oncology Sterile Injectable Market Share Forecast by Application (2021-2025)
13 Sales Channel, Distributors, Traders and Dealers
13.1 Sales Channel
13.1.1 Direct Marketing
13.1.2 Indirect Marketing
13.2 Distributors, Traders and Dealers
14 Research Findings and Conclusion
15 Appendix
15.1 Methodology
15.2 Data Source
15.3 Disclaimer
15.4 About US
Table 1. Global Generic Oncology Sterile Injectable Revenue (USD Million) by Type: 2015 VS 2019 VS 2025
Table 2. Breakdown of Generic Oncology Sterile Injectable by Company Type (Tier 1, Tier 2 and Tier 3)
Table 3. Global Generic Oncology Sterile Injectable Revenue (USD Million) by Application: 2015 VS 2019 VS 2025
Table 4. Market Opportunities in Next Few Years
Table 5. Market Risks Analysis
Table 6. Market Drivers
Table 7. Eli Lilly & Company Basic Information, Manufacturing Base and Competitors
Table 8. Eli Lilly & Company Generic Oncology Sterile Injectable Major Business
Table 9. Eli Lilly & Company Generic Oncology Sterile Injectable Total Revenue (USD Million) (2017-2018)
Table 10. Eli Lilly & Company SWOT Analysis
Table 11. Eli Lilly & Company Generic Oncology Sterile Injectable Product and Services
Table 12. Eli Lilly & Company Generic Oncology Sterile Injectable Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
Table 13. Pfizer Inc Basic Information, Manufacturing Base and Competitors
Table 14. Pfizer Inc Generic Oncology Sterile Injectable Major Business
Table 15. Pfizer Inc Generic Oncology Sterile Injectable Total Revenue (USD Million) (2017-2018)
Table 16. Pfizer Inc SWOT Analysis
Table 17. Pfizer Inc Generic Oncology Sterile Injectable Product and Services
Table 18. Pfizer Inc Generic Oncology Sterile Injectable Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
Table 19. Hikma Pharmaceuticals PLC Basic Information, Manufacturing Base and Competitors
Table 20. Hikma Pharmaceuticals PLC Generic Oncology Sterile Injectable Major Business
Table 21. Hikma Pharmaceuticals PLC Generic Oncology Sterile Injectable Total Revenue (USD Million) (2017-2018)
Table 22. Hikma Pharmaceuticals PLC SWOT Analysis
Table 23. Hikma Pharmaceuticals PLC Generic Oncology Sterile Injectable Product and Services
Table 24. Hikma Pharmaceuticals PLC Generic Oncology Sterile Injectable Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
Table 25. Biocon Ltd Basic Information, Manufacturing Base and Competitors
Table 26. Biocon Ltd Generic Oncology Sterile Injectable Major Business
Table 27. Biocon Ltd Generic Oncology Sterile Injectable Total Revenue (USD Million) (2017-2018)
Table 28. Biocon Ltd SWOT Analysis
Table 29. Biocon Ltd Generic Oncology Sterile Injectable Product and Services
Table 30. Biocon Ltd Generic Oncology Sterile Injectable Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
Table 31. Teva Pharmaceutical Industries Ltd. Basic Information, Manufacturing Base and Competitors
Table 32. Teva Pharmaceutical Industries Ltd. Generic Oncology Sterile Injectable Major Business
Table 33. Teva Pharmaceutical Industries Ltd. Generic Oncology Sterile Injectable Total Revenue (USD Million) (2017-2018)
Table 34. Teva Pharmaceutical Industries Ltd. SWOT Analysis
Table 35. Teva Pharmaceutical Industries Ltd. Generic Oncology Sterile Injectable Product and Services
Table 36. Teva Pharmaceutical Industries Ltd. Generic Oncology Sterile Injectable Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
Table 37. Baxter International Inc Basic Information, Manufacturing Base and Competitors
Table 38. Baxter International Inc Generic Oncology Sterile Injectable Major Business
Table 39. Baxter International Inc Generic Oncology Sterile Injectable Total Revenue (USD Million) (2017-2018)
Table 40. Baxter International Inc SWOT Analysis
Table 41. Baxter International Inc Generic Oncology Sterile Injectable Product and Services
Table 42. Baxter International Inc Generic Oncology Sterile Injectable Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
Table 43. Sandoz International GmbH Basic Information, Manufacturing Base and Competitors
Table 44. Sandoz International GmbH Generic Oncology Sterile Injectable Major Business
Table 45. Sandoz International GmbH Generic Oncology Sterile Injectable Total Revenue (USD Million) (2017-2018)
Table 46. Sandoz International GmbH SWOT Analysis
Table 47. Sandoz International GmbH Generic Oncology Sterile Injectable Product and Services
Table 48. Sandoz International GmbH Generic Oncology Sterile Injectable Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
Table 49. Mylan N.V Basic Information, Manufacturing Base and Competitors
Table 50. Mylan N.V Generic Oncology Sterile Injectable Major Business
Table 51. Mylan N.V Generic Oncology Sterile Injectable Total Revenue (USD Million) (2017-2018)
Table 52. Mylan N.V SWOT Analysis
Table 53. Mylan N.V Generic Oncology Sterile Injectable Product and Services
Table 54. Mylan N.V Generic Oncology Sterile Injectable Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
Table 55. Global Generic Oncology Sterile Injectable Sales by Manufacturer (2018-2019) (K Units)
Table 56. Global Generic Oncology Sterile Injectable Revenue by Manufacturer (2018-2019) (USD Million)
Table 57. Global Generic Oncology Sterile Injectable Sales by Regions (2015-2020) (K Units)
Table 58. Global Generic Oncology Sterile Injectable Sales Market Share by Regions (2015-2020)
Table 59. Global Generic Oncology Sterile Injectable Revenue by Regions (2015-2020) (USD Million)
Table 60. North America Generic Oncology Sterile Injectable Sales by Countries (2015-2020) (K Units)
Table 61. North America Generic Oncology Sterile Injectable Sales Market Share by Countries (2015-2020)
Table 62. North America Generic Oncology Sterile Injectable Revenue by Countries (2015-2020) (USD Million)
Table 63. North America Generic Oncology Sterile Injectable Revenue Market Share by Countries (2015-2020)
Table 64. Europe Generic Oncology Sterile Injectable Sales by Countries (2015-2020) (K Units)
Table 65. Europe Generic Oncology Sterile Injectable Sales Market Share by Countries (2015-2020)
Table 66. Europe Generic Oncology Sterile Injectable Revenue by Countries (2015-2020) (USD Million)
Table 67. Asia-Pacific Generic Oncology Sterile Injectable Sales by Regions (2015-2020) (K Units)
Table 68. Asia-Pacific Generic Oncology Sterile Injectable Sales Market Share by Regions (2015-2020)
Table 69. Asia-Pacific Generic Oncology Sterile Injectable Revenue by Regions (2015-2020) (USD Million)
Table 70. South America Generic Oncology Sterile Injectable Sales by Countries (2015-2020) (K Units)
Table 71. South America Generic Oncology Sterile Injectable Sales Market Share by Countries (2015-2020)
Table 72. South America Generic Oncology Sterile Injectable Revenue by Countries (2015-2020) (USD Million)
Table 73. South America Generic Oncology Sterile Injectable Revenue Market Share by Countries (2015-2020)
Table 74. Middle East & Africa Generic Oncology Sterile Injectable Sales by Countries (2015-2020) (K Units)
Table 75. Middle East & Africa Generic Oncology Sterile Injectable Sales Market Share by Countries (2015-2020)
Table 76. Middle East & Africa Generic Oncology Sterile Injectable Revenue by Countries (2015-2020) (USD Million)
Table 77. Middle East & Africa Generic Oncology Sterile Injectable Revenue Market Share by Countries (2015-2020)
Table 78. Global Generic Oncology Sterile Injectable Sales by Type (2015-2020) (K Units)
Table 79. Global Generic Oncology Sterile Injectable Sales Share by Type (2015-2020)
Table 80. Global Generic Oncology Sterile Injectable Revenue by Type (2015-2020) (USD Million)
Table 81. Global Generic Oncology Sterile Injectable Revenue Share by Type (2015-2020)
Table 82. Global Generic Oncology Sterile Injectable Sales by Application (2015-2020) (K Units)
Table 83. Global Generic Oncology Sterile Injectable Sales Share by Application (2015-2020)
Table 84. Global Generic Oncology Sterile Injectable Sales Forecast by Regions (2021-2025) (K Units)
Table 85. Global Generic Oncology Sterile Injectable Market Share Forecast by Regions (2021-2025)
Table 86. Global Generic Oncology Sterile Injectable Sales Forecast by Type (2021-2025) (K Units)
Table 87. Global Generic Oncology Sterile Injectable Market Share Forecast by Type (2021-2025)
Table 88. Global Generic Oncology Sterile Injectable Sales Forecast by Application (2021-2025)
Table 89. Global Generic Oncology Sterile Injectable Market Share Forecast by Application (2021-2025)
Table 90. Direct Channel Pros & Cons
Table 91. Indirect Channel Pros & Cons
Table 92. Distributors/Traders/ Dealers List
List of Figures
Figure 1. Generic Oncology Sterile Injectable Picture
Figure 2. Global Sales Market Share of Generic Oncology Sterile Injectable by Type in 2019
Figure 3. Chemotherapy Picture
Figure 4. Monoclonal Antibodies Picture
Figure 5. Cytokines Picture
Figure 6. Peptide Hormones Picture
Figure 7. Generic Oncology Sterile Injectable Sales Market Share by Application in 2018
Figure 8. Hospital Pharmacies Picture
Figure 9. Retail Pharmacies Picture
Figure 10. Online Pharmacies Picture
Figure 11. Global Generic Oncology Sterile Injectable Market Status and Outlook (2015-2025) (USD Million)
Figure 12. United States Generic Oncology Sterile Injectable Revenue (Value) and Growth Rate (2015-2025)
Figure 13. Canada Generic Oncology Sterile Injectable Revenue (Value) and Growth Rate (2015-2025)
Figure 14. Mexico Generic Oncology Sterile Injectable Revenue (Value) and Growth Rate (2015-2025)
Figure 15. Germany Generic Oncology Sterile Injectable Revenue (Value) and Growth Rate (2015-2025)
Figure 16. France Generic Oncology Sterile Injectable Revenue (Value) and Growth Rate (2015-2025)
Figure 17. UK Generic Oncology Sterile Injectable Revenue (Value) and Growth Rate (2015-2025)
Figure 18. Russia Generic Oncology Sterile Injectable Revenue (Value) and Growth Rate (2015-2025)
Figure 19. Italy Generic Oncology Sterile Injectable Revenue (Value) and Growth Rate (2015-2025)
Figure 20. China Generic Oncology Sterile Injectable Revenue (Value) and Growth Rate (2015-2025)
Figure 21. Japan Generic Oncology Sterile Injectable Revenue (Value) and Growth Rate (2015-2025)
Figure 22. Korea Generic Oncology Sterile Injectable Revenue (Value) and Growth Rate (2015-2025)
Figure 23. India Generic Oncology Sterile Injectable Revenue (Value) and Growth Rate (2015-2025)
Figure 24. Southeast Asia Generic Oncology Sterile Injectable Revenue (Value) and Growth Rate (2015-2025)
Figure 25. Australia Generic Oncology Sterile Injectable Revenue (Value) and Growth Rate (2015-2025) (USD Million)
Figure 26. Brazil Generic Oncology Sterile Injectable Revenue (Value) and Growth Rate (2015-2025)
Figure 27. Egypt Generic Oncology Sterile Injectable Revenue (Value) and Growth Rate (2015-2025)
Figure 28. Saudi Arabia Generic Oncology Sterile Injectable Revenue (Value) and Growth Rate (2015-2025)
Figure 29. South Africa Generic Oncology Sterile Injectable Revenue (Value) and Growth Rate (2015-2025)
Figure 30. Turkey Generic Oncology Sterile Injectable Revenue (Value) and Growth Rate (2015-2025)
Figure 31. Global Generic Oncology Sterile Injectable Sales Market Share by Manufacturer in 2019
Figure 32. Global Generic Oncology Sterile Injectable Revenue Market Share by Manufacturer in 2019
Figure 33. Top 3 Generic Oncology Sterile Injectable Manufacturer (Revenue) Market Share in 2019
Figure 34. Top 6 Generic Oncology Sterile Injectable Manufacturer (Revenue) Market Share in 2019
Figure 35. Key Manufacturer Market Share Trend
Figure 36. Global Generic Oncology Sterile Injectable Sales and Growth Rate (2015-2020) (K Units)
Figure 37. Global Generic Oncology Sterile Injectable Revenue and Growth Rate (2015-2020) (USD Million)
Figure 38. Global Generic Oncology Sterile Injectable Revenue Market Share by Regions (2015-2020)
Figure 39. Global Generic Oncology Sterile Injectable Revenue Market Share by Regions in 2018
Figure 40. North America Generic Oncology Sterile Injectable Sales and Growth Rate (2015-2020)
Figure 41. Europe Generic Oncology Sterile Injectable Sales and Growth Rate (2015-2020)
Figure 42. Asia-Pacific Generic Oncology Sterile Injectable Sales and Growth Rate (2015-2020)
Figure 43. South America Generic Oncology Sterile Injectable Sales and Growth Rate (2015-2020)
Figure 44. Middle East & Africa Generic Oncology Sterile Injectable Sales and Growth Rate (2015-2020)
Figure 45. North America Generic Oncology Sterile Injectable Revenue and Growth Rate (2015-2020) (USD Million)
Figure 46. North America Generic Oncology Sterile Injectable Sales Market Share by Countries (2015-2020)
Figure 47. North America Generic Oncology Sterile Injectable Sales Market Share by Countries in 2018
Figure 48. North America Generic Oncology Sterile Injectable Revenue Market Share by Countries (2015-2020) (USD Million)
Figure 49. North America Generic Oncology Sterile Injectable Revenue Market Share by Countries in 2018
Figure 50. United States Generic Oncology Sterile Injectable Sales and Growth Rate (2015-2020) (K Units)
Figure 51. Canada Generic Oncology Sterile Injectable Sales and Growth Rate (2015-2020) (K Units)
Figure 52. Mexico Generic Oncology Sterile Injectable Sales and Growth Rate (2015-2020) (K Units)
Figure 53. Europe Generic Oncology Sterile Injectable Revenue and Growth Rate (2015-2020) (USD Million)
Figure 54. Europe Generic Oncology Sterile Injectable Revenue Market Share by Countries (2015-2020)
Figure 55. Europe Generic Oncology Sterile Injectable Revenue Market Share by Countries in 2019
Figure 56. Germany Generic Oncology Sterile Injectable Sales and Growth Rate (2015-2020) (K Units)
Figure 57. UK Generic Oncology Sterile Injectable Sales and Growth Rate (2015-2020) (K Units)
Figure 58. France Generic Oncology Sterile Injectable Sales and Growth Rate (2015-2020) (K Units)
Figure 59. Russia Generic Oncology Sterile Injectable Sales and Growth Rate (2015-2020) (K Units)
Figure 60. Italy Generic Oncology Sterile Injectable Sales and Growth Rate (2015-2020) (K Units)
Figure 61. Asia-Pacific Generic Oncology Sterile Injectable Revenue and Growth Rate (2015-2020) (USD Million)
Figure 62. Asia-Pacific Generic Oncology Sterile Injectable Sales Market Share by Regions 2019
Figure 63. Asia-Pacific Generic Oncology Sterile Injectable Revenue Market Share by Regions 2019
Figure 64. China Generic Oncology Sterile Injectable Sales and Growth Rate (2015-2020) (K Units)
Figure 65. Japan Generic Oncology Sterile Injectable Sales and Growth Rate (2015-2020) (K Units)
Figure 66. Korea Generic Oncology Sterile Injectable Sales and Growth Rate (2015-2020) (K Units)
Figure 67. India Generic Oncology Sterile Injectable Sales and Growth Rate (2015-2020) (K Units)
Figure 68. Southeast Asia Generic Oncology Sterile Injectable Sales and Growth Rate (2015-2020) (K Units)
Figure 69. South America Generic Oncology Sterile Injectable Revenue and Growth Rate (2015-2020) (USD Million)
Figure 70. South America Generic Oncology Sterile Injectable Sales Market Share by Countries in 2019
Figure 71. South America Generic Oncology Sterile Injectable Revenue Market Share by Countries in 2019
Figure 72. Brazil Generic Oncology Sterile Injectable Sales and Growth Rate (2015-2020) (K Units)
Figure 73. Argentina Generic Oncology Sterile Injectable Sales and Growth Rate (2015-2020) (K Units)
Figure 74. Middle East and Africa Generic Oncology Sterile Injectable Revenue and Growth Rate (2015-2020) (USD Million)
Figure 75. Middle East and Africa Generic Oncology Sterile Injectable Sales Market Share by Countries in 2019
Figure 76. Middle East and Africa Generic Oncology Sterile Injectable Revenue Market Share by Countries (2015-2020)
Figure 77. Middle East and Africa Generic Oncology Sterile Injectable Revenue Market Share by Countries in 2019
Figure 78. Saudi Arabia Generic Oncology Sterile Injectable Sales and Growth Rate (2015-2020) (K Units)
Figure 79. Egypt Generic Oncology Sterile Injectable Sales and Growth Rate (2015-2020) (K Units)
Figure 80. Turkey Generic Oncology Sterile Injectable Sales and Growth Rate (2015-2020) (K Units)
Figure 81. South Africa Generic Oncology Sterile Injectable Sales and Growth Rate (2015-2020) (K Units)
Figure 82. Global Generic Oncology Sterile Injectable Sales and Growth Rate (2021-2025) (K Units)
Figure 83. Global Generic Oncology Sterile Injectable Revenue and Growth Rate (2021-2025) (USD Million)
Figure 84. North America Sales Generic Oncology Sterile Injectable Market Forecast (2021-2025) (K Units)
Figure 85. Europe Sales Generic Oncology Sterile Injectable Market Forecast (2021-2025) (K Units)
Figure 86. Asia-Pacific Sales Generic Oncology Sterile Injectable Market Forecast (2021-2025) (K Units)
Figure 87. South America Sales Generic Oncology Sterile Injectable Market Forecast (2021-2025) (K Units)
Figure 88. Middle East & Africa Sales Generic Oncology Sterile Injectable Market Forecast (2021-2025) (K Units)
Figure 89. Sales Channel: Direct Channel vs Indirect Channel
一般無菌注射の世界市場 2020年：メーカー別、地域別、種類・用途別 Market Overview The global Generic Sterile Injectable market size is expected to gain market growth in the forecast period of 2020 to 2025, with a CAGR of 5.5% in the forecast period of 2020 to 2025 and will expected to reach USD 63660 million by 2025, from USD 51320 million in 2019. The Generic Ste…- 無菌注射薬の世界市場 2020年：メーカー別、地域別、種類・用途別 Market Overview The global Sterile Injectable Drugs market size is expected to gain market growth in the forecast period of 2020 to 2025, with a CAGR of 5.0% in the forecast period of 2020 to 2025 and will expected to reach USD 4258.5 million by 2025, from USD 3506.7 million in 2019. The Sterile Inj…
- 滅菌注射剤の世界市場 2020年：メーカー別、地域別、種類・用途別 Market Overview The global Sterile Injectables market size is expected to gain market growth in the forecast period of 2020 to 2025, with a CAGR of 4.0% in the forecast period of 2020 to 2025 and will expected to reach USD 377.3 million by 2025, from USD 323 million in 2019. The Sterile Injectables …
- 無菌サンプリングシステムの世界市場 2020年：メーカー別、地域別、種類・用途別 Market Overview The global Sterile Sampling Systems market size is expected to gain market growth in the forecast period of 2020 to 2025, with a CAGR of xx% in the forecast period of 2020 to 2025 and will expected to reach USD xx million by 2025, from USD xx million in 2019. The Sterile Sampling Sys…
- 免疫腫瘍薬の世界市場 2020年：メーカー別、地域別、種類・用途別 Market Overview The global Immuno-oncology Drugs market size is expected to gain market growth in the forecast period of 2020 to 2025, with a CAGR of 8.1% in the forecast period of 2020 to 2025 and will expected to reach USD 73080 million by 2025, from USD 53550 million in 2019. The Immuno-oncology …